Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Centogene stock

CNTGF
NL0014040206
A2PUCU

Price

0.32
Today +/-
+0.08
Today %
+29.69 %
P

Centogene stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Centogene stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Centogene stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Centogene stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Centogene's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Centogene Stock Price History

DateCentogene Price
10/1/20240.32 undefined
9/30/20240.23 undefined
9/27/20240.18 undefined
9/25/20240.16 undefined
9/24/20240.18 undefined
9/23/20240.14 undefined
9/20/20240.24 undefined
9/19/20240.13 undefined
9/18/20240.19 undefined
9/17/20240.18 undefined
9/16/20240.17 undefined
9/13/20240.06 undefined
9/12/20240.10 undefined
9/11/20240.14 undefined
9/10/20240.06 undefined
9/9/20240.10 undefined
9/6/20240.10 undefined
9/5/20240.10 undefined
9/4/20240.10 undefined

Centogene Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Centogene, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Centogene from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Centogene’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Centogene. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Centogene’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Centogene’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Centogene’s growth potential.

Centogene Revenue, EBIT and net profit per share

DateCentogene RevenueCentogene EBITCentogene Net Income
2024e61.29 M undefined-40.79 M undefined-27.58 M undefined
202348.54 M undefined-28.03 M undefined-35.53 M undefined
202247.47 M undefined-35.92 M undefined-31.84 M undefined
202142.23 M undefined-54.65 M undefined-46.25 M undefined
202038.45 M undefined-50.1 M undefined-21.99 M undefined
201948.78 M undefined-18.13 M undefined-20.86 M undefined
201840.48 M undefined-10.51 M undefined-11.34 M undefined
201731.69 M undefined-4.54 M undefined-5.48 M undefined
201627.67 M undefined-5.03 M undefined-5.36 M undefined

Centogene Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201620172018201920202021202220232024e
273140483842474861
-14.8129.0320.00-20.8310.5311.902.1327.08
51.8551.6150.0045.8318.4233.3340.4335.42-
1416202271419170
-5-4-10-18-50-54-35-28-40
-18.52-12.90-25.00-37.50-131.58-128.57-74.47-58.33-65.57
-5-5-11-20-21-46-31-35-27
--120.0081.825.00119.05-32.6112.90-22.86
19.8619.8619.8619.8620.9122.4426.8128.160
---------
Details

Keystats

ⓘ

Revenue and Growth

The Centogene Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Centogene is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20162017201820192020202120222023
               
13.29.241.148.217.83619.1
4.6710.916.62923.516.519.42
00000000
0.40.81.31.811.43.91.82.46
2.72.57.38.68.35.55.53.04
8.713.528.768.196.950.759.844.02
20.333.839.133.338.728.422.219.28
0000000.53.58
00000000
6.37.58.814.112.49.27.46.85
00000000
1.10.701.9232.93.43
27.74247.949.353.140.63333.14
36.455.576.6117.415091.392.877.16
               
0.20.30.32.42.72.73.33.48
00000000
2.816.52757.562.224.44.1-28.76
00000000
00000000
316.827.359.964.927.17.4-25.28
65.35.48.631.711.36.35.63
00000000
3.6313.813.119.42111.49.68
0002.61.93.33.425.88
14.315.55.14.74.13.83.62.18
23.923.824.32957.139.424.743.37
5.43.914.619.618.115.453.252.28
400400002001000407
3.811.111.29.99.697.56.39
9.615.425.829.527.924.560.759.07
33.539.250.158.58563.985.4102.44
36.55677.4118.4149.99192.877.16
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Centogene provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Centogene's financial health and stability.

Assets

Centogene's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Centogene must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Centogene after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Centogene's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)

Centogene stock margins

The Centogene margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Centogene. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Centogene.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Centogene's sales revenue. A higher gross margin percentage indicates that the Centogene retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Centogene's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Centogene's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Centogene's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Centogene. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Centogene's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Centogene Margin History

Centogene Gross marginCentogene Profit marginCentogene EBIT marginCentogene Profit margin
2024e36.46 %-66.55 %-44.99 %
202336.46 %-57.74 %-73.21 %
202241.96 %-75.67 %-67.07 %
202134.5 %-129.41 %-109.52 %
202020.47 %-130.3 %-57.19 %
201946.7 %-37.17 %-42.76 %
201850.74 %-25.96 %-28.01 %
201752.86 %-14.33 %-17.29 %
201653.52 %-18.18 %-19.37 %

Centogene Stock Sales Revenue, EBIT, Earnings per Share

The Centogene earnings per share therefore indicates how much revenue Centogene has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Centogene earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Centogene's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Centogene’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Centogene's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Centogene Revenue, EBIT and net profit per share

DateCentogene Sales per ShareCentogene EBIT per shareCentogene Earnings per Share
2024e2.22 undefined0 undefined-1 undefined
20231.72 undefined-1 undefined-1.26 undefined
20221.77 undefined-1.34 undefined-1.19 undefined
20211.88 undefined-2.44 undefined-2.06 undefined
20201.84 undefined-2.4 undefined-1.05 undefined
20192.46 undefined-0.91 undefined-1.05 undefined
20182.04 undefined-0.53 undefined-0.57 undefined
20171.6 undefined-0.23 undefined-0.28 undefined
20161.39 undefined-0.25 undefined-0.27 undefined

Centogene business model

Centogene NV is a biotechnology company specializing in the research and diagnosis of rare genetic diseases. It was founded in 2006 by Arndt Rolfs and Christoph Lengauer in Rostock. The business model of Centogene NV is based on the application of genomic research and advanced technologies to develop novel diagnostic and therapeutic approaches. The company operates its own laboratories where DNA samples are analyzed and evaluated. The goal is to identify the genetic causes of rare diseases and provide patients with personalized treatment options. The company operates in several areas. One focus is on the diagnosis of rare diseases that have unclear genetic causes. The company offers a wide range of genetic tests that aim to enable fast and precise diagnosis. These include exome sequencing, RNA analysis, and gene panel tests. Another business field of Centogene NV is the development of new therapy approaches for rare diseases. The company collaborates with pharmaceutical companies and clinical researchers to develop innovative drugs and conduct clinical trials. The aim is to offer improved treatment options and enhance the quality of life for patients with rare diseases. Centogene NV is headquartered in Rostock, Germany, but also has offices in Lisbon, Portugal, Dubai, United Arab Emirates, and Boston, USA. The company operates globally and collaborates with medical centers and research laboratories worldwide. A special feature of Centogene NV is the CentoMD® database system. This is an extensive genetic database that contains clinical and genetic information from patients with rare diseases. This database is a valuable resource for diagnosis, research, and the development of new therapy approaches. The company works closely with patient groups and international organizations to raise awareness of rare diseases and create better treatment options. Centogene NV is also involved in the education and training of medical professionals to ensure better care for patients. Overall, Centogene NV is a leading company in the research and diagnosis of rare genetic diseases. The business model is based on the application of cutting-edge genomic research and technologies to provide patients with personalized treatment options. The company operates globally and has its own laboratories and extensive genetic database. Centogene NV is actively involved in research and education to improve the care of patients with rare diseases. Centogene is one of the most popular companies on Eulerpool.com.

Centogene SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Centogene Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Centogene historical P/E ratio, EBIT multiple, and P/S ratio

Centogene shares outstanding

The number of shares was Centogene in 2023 — This indicates how many shares 28.163 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Centogene earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Centogene's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Centogene’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Centogene's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Centogene.

Centogene latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/2022-0.38 -0.09  (76.38 %)2022 Q4
9/30/2022-0.41 -0.47  (-14.08 %)2022 Q3
6/30/2022-0.4 -0.38  (5.4 %)2022 Q2
3/31/2022-0.52 -0.48  (6.8 %)2022 Q1
12/31/2021-0.65 -0.51  (21.41 %)2021 Q4
9/30/2021-0.5 -0.96  (-90.21 %)2021 Q3
6/30/2021-0.24 -0.37  (-53.21 %)2021 Q2
3/31/20210.04 -0.22  (-621.33 %)2021 Q1
12/31/2020-0.08 0.18  (318.45 %)2020 Q4
9/30/2020-0.24 -0.27  (-13.11 %)2020 Q3
1
2

Eulerpool ESG Scorecard© for the Centogene stock

Eulerpool World ESG Rating (EESG©)

60/ 100

🌱 Environment

62

👫 Social

82

🏛️ Governance

37

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Centogene shareholders

%
Name
Stocks
Change
Date
8.61030 % Platinum Asset Management2,376,442-70812/31/2023
28.04224 % DPE Deutsche Private Equity GmbH7,739,658012/31/2022
15.44007 % Careventures S.A.4,261,4601,313,86612/31/2022
11.32476 % TVM Capital GmbH3,125,635-857,14212/31/2022
1.28441 % ACATIS Investment Kapitalverwaltungsgesellschaft GmbH354,49801/31/2024
1.26864 % Friedrich (Holger)350,145012/31/2022
1.08696 % Ornskov (Flemming)300,000300,00012/31/2022
0.74416 % Wells Fargo Advisors205,389-1,00012/31/2023
0.36268 % Schatz (Peer M)100,10075,10012/31/2022
0.07772 % Stifel, Nicolaus & Company, Incorporated21,4505,00012/31/2023
1
2
3
4

Most common questions regarding Centogene

What values and corporate philosophy does Centogene represent?

Centogene NV represents values centered around innovation, collaboration, and excellence in the field of rare genetic diseases and diagnostics. With a philosophy rooted in personalized medicine, Centogene strives to improve patient outcomes by identifying and understanding rare diseases at a genetic level. By employing advanced technologies and leveraging extensive genetic data, Centogene aims to provide patients and healthcare professionals with accurate and timely diagnosis, enabling targeted therapies and enhancing overall quality of life. Centogene's commitment to continuous research, cutting-edge technology, and patient-centric approach positions the company as a leading player in the field of rare genetic diseases.

In which countries and regions is Centogene primarily present?

Centogene NV is primarily present in various countries and regions worldwide. The company operates in Europe, including Germany, Switzerland, and Austria, as well as the United States. Centogene NV's presence is also notable in the Middle East, with offices located in Dubai. Additionally, the company has a substantial presence in several Asian countries, such as India and Japan. Furthermore, Centogene NV extends its reach to Latin America, particularly in countries like Brazil and Mexico. The company's global presence allows it to provide comprehensive genetic testing and diagnostics services worldwide.

What significant milestones has the company Centogene achieved?

Centogene NV has achieved several significant milestones. The company, known for its pioneering work in the field of rare genetic diseases, has successfully established a vast genomic database that aids in the diagnosis and treatment of these conditions. Centogene NV has also developed proprietary technologies for genetic sequencing and analysis, ensuring accurate and timely results for patients worldwide. Moreover, the company has formed strategic partnerships with leading pharmaceutical and biotechnology firms, facilitating collaborative efforts in research and development. With its continuous focus on innovation and dedication to improving patient outcomes, Centogene NV has become a trusted name in the field of genetic diagnostics and rare diseases.

What is the history and background of the company Centogene?

Centogene NV is a biotech company specializing in rare genetic diseases. Founded in 2006, Centogene has become a global leader in diagnostics and research for orphan diseases. The company uses genomic and clinical data to provide personalized insights to patients, physicians, and pharmaceutical companies. Centogene operates a state-of-the-art laboratory in Germany and serves patients and partners worldwide. With its extensive genetic database and advanced analytics, Centogene aims to accelerate the development of targeted therapies and improve patient outcomes. The company's commitment to cutting-edge research and innovation has positioned it as a trusted partner in the field of rare genetic diseases.

Who are the main competitors of Centogene in the market?

The main competitors of Centogene NV in the market are companies such as Invitae Corporation, Genomic Health Inc., and Myriad Genetics Inc.

In which industries is Centogene primarily active?

Centogene NV is primarily active in the biotechnology and genetic diagnostics industries.

What is the business model of Centogene?

Centogene NV operates with a diagnostics business model. It specializes in rare diseases, offering genetic testing and analysis services to identify such conditions. Centogene NV uses advanced technologies and data analysis to provide insights into these diseases, aiming to improve patient outcomes and enhance the understanding of rare genetic disorders. By collaborating with pharmaceutical companies, Centogene NV contributes to the development of targeted therapies and personalized medicine. The company's comprehensive approach combines clinical data, genetic expertise, and vast databases to support the identification, diagnosis, and management of rare diseases. Centogene NV is committed to enabling early detection and accurate diagnosis for patients worldwide.

What is the P/E ratio of Centogene 2024?

The Centogene P/E ratio is -0.32.

What is the P/S ratio of Centogene 2024?

The Centogene P/S ratio is 0.15.

What is the AlleAktien quality score of Centogene?

The AlleAktien quality score for Centogene is 4/10.

What is the revenue of Centogene 2024?

The expected Centogene revenue is 61.29 M EUR.

How high is the profit of Centogene 2024?

The expected Centogene profit is -27.58 M EUR.

What is the business model of Centogene

Centogene NV is a globally active company specializing in the development of diagnostic tests and solutions for rare genetic diseases. It offers a wide range of products including genetic tests, databases, analysis tools, and consulting services. The company works closely with patients, doctors, and researchers to develop solutions for the diagnosis and treatment of rare diseases. Centogene NV has a comprehensive network of partners and collaborations worldwide and operates laboratories in Europe and the US. Its key areas of focus include diagnostics, genetic databases, analysis tools and consulting services, as well as research and development. The company plays a crucial role in improving the understanding and treatment of rare diseases.

What is the Centogene dividend?

Centogene pays a dividend of 0 EUR distributed over payouts per year.

How often does Centogene pay dividends?

The dividend cannot currently be calculated for Centogene or the company does not pay out a dividend.

What is the Centogene ISIN?

The ISIN of Centogene is NL0014040206.

What is the Centogene WKN?

The WKN of Centogene is A2PUCU.

What is the Centogene ticker?

The ticker of Centogene is CNTGF.

How much dividend does Centogene pay?

Over the past 12 months, Centogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Centogene is expected to pay a dividend of 0 EUR.

What is the dividend yield of Centogene?

The current dividend yield of Centogene is .

When does Centogene pay dividends?

Centogene pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Centogene?

Centogene paid dividends every year for the past 0 years.

What is the dividend of Centogene?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Centogene located?

Centogene is assigned to the 'Health' sector.

Wann musste ich die Aktien von Centogene kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Centogene from 10/3/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Centogene pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Centogene in the year 2023?

In the year 2023, Centogene distributed 0 EUR as dividends.

In which currency does Centogene pay out the dividend?

The dividends of Centogene are distributed in EUR.

All fundamentals about Centogene

Our stock analysis for Centogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Centogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.